.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.comments
.
. we have let patients down, admits senior northern ireland civil servant
.
.
$17
OFF DEAL
OFF DEAL
50%
OFF DEAL
OFF DEAL